Celltrion won in the appellate courts in patent dispute over the trademark right of rheumatoid arthritis Remsima between Janssen
Celltrion won in the appellate courts in patent dispute over the trademark right of rheumatoid arthritis Remsima between Janssen. Janssen had filed a nullity trial of Remsima with the reason that Celltrion's biosimilar Remsima infringed patent right of Remicade.
On August 24, according to the re...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
